Mijun Ranjan Nath

Mijun Ranjan Nath

Active Director Director DIN 06780698
DIN 06780698 First appointment Mar 2014 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Mijun Ranjan Nath

Data last updated:

Mijun Ranjan Nath is a Director at Signatra Pharmaceuticals Private Limited (since 2014). The company operates in Chemicals.

DIN 06780698
Primary Designation Director
Industry Chemicals
First Appointment 05 Mar 2014
Oldest Company Age 12 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Mar 20142014Active

Board colleagues of Mijun Ranjan Nath

NameDINCompanyDesignation
Minu Nath07395575Signatra Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Signatra Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mijun Ranjan Nath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mijun Ranjan Nath

Mijun Ranjan Nath currently holds 1 directorship: Signatra Pharmaceuticals Private Limited (Director, since 05 Mar 2014).

Mijun Ranjan Nath was first appointed on 05 Mar 2014 as Director at Signatra Pharmaceuticals Private Limited.

The current boards of Mijun Ranjan Nath's companies include Minu Nath (Signatra Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available